Can a pill help Huntington's patients speak and walk better?
NCT ID NCT04713982
Summary
This study is testing if a medication called deutetrabenazine can help improve speech clarity and walking stability in people with Huntington's disease. Over two years, 30 participants will have their speech and movement carefully measured before and after starting the drug. The goal is to see if the medication helps control these specific movement problems caused by the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.